首页> European journal of cancer (Oxford, England : 1990)> Poziotinib for EGFR and HER2 exon 20 insertion mutation in advanced NSCLC: Results from the expanded access program.

Poziotinib for EGFR and HER2 exon 20 insertion mutation in advanced NSCLC: Results from the expanded access program.

导出 LinkOut

翻译打印收藏纠错

第一作者： Arsela,Prelaj

第一单位： Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Via Giacomo Venezian 1, 20133, Milan, Italy; Department of Electronics, Information, and Bioengineering, Polytechnic University of Milan, Piazza L. da Vinci 32, Milano, 20133, Italy. Electronic address: arsela.prelaj@istitutotumori.mi.it.

作者： Arsela,Prelaj ^[1] ; Achille,Bottiglieri ^[2] ; Claudia,Proto ^[2] ; Giuseppe,Lo Russo ^[2] ; Diego,Signorelli ^[2] ; Roberto,Ferrara ^[2] ; Giulia,Galli ^[2] ; Alessandro,De Toma ^[2] ; Giuseppe,Viscardi ^[2] ; Marta,Brambilla ^[2] ; Riccardo,Lobefaro ^[2] ; Federico,Nichetti ^[2] ; Sara,Manglaviti ^[2] ; Mario,Occhipinti ^[2] ; Alice,Labianca ^[2] ; Monica,Ganzinelli ^[2] ; Rosaria,Gallucci ^[2] ; Nicoletta,Zilembo ^[2] ; Gabriella Francesca,Greco ^[3] ; Valter,Torri ^[4] ; Filippo,de Braud ^[2] ; Marina C,Garassino ^[2]

作者单位： Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Via Giacomo Venezian 1, 20133, Milan, Italy; Department of Electronics, Information, and Bioengineering, Polytechnic University of Milan, Piazza L. da Vinci 32, Milano, 20133, Italy. Electronic address: arsela.prelaj@istitutotumori.mi.it. ^[1] Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Via Giacomo Venezian 1, 20133, Milan, Italy. ^[2] Department of Radiology, Fondazione IRCCS Istituto Nazionale Dei Tumori di Milano, Via Giacomo Venezian 1, 20133, Milan, Italy. ^[3] Department of Oncology, IRCCS "Mario Negri" Institute, Milano, Via La Masa 19, 20156, Milano, Italy. ^[4]

关键词 EGFR Exon 20 insertion mutation HER2 NSCLC Poziotinib